print this page

PGY-2 Critical Care Pharmacy Residency At-A-Glance

The Baystate Medical Center PGY2 Critical Care Pharmacy Residency Program is designed for the resident. We strive to offer flexibility and customization to accommodate resident career goals and interest areas. We participate in the ASHP residency match and are pending accreditation.

Chief Pharmacy Officer: Gary J. Kerr, MBA, PharmD | Director of Pharmacy: Aaron Michelucci, PharmD

Residency Program Director:  Adam B. Pesaturo, PharmD, BCPS   email:  phone: 413-794-1181

Program and Department Statistics

  • Affiliation: Massachusetts College of Pharmacy—Worcester
  • Length of Program: 12 months
  • Residents Accepted into Program: 1
  • Start Date: July 1
  • Total Number of Pharmacy Staff: 130+

Baystate Statistics

  • Tertiary Care Referral Center
  • Level 1 Trauma Center
  • Home to Western New England’s only Neonatal and Pediatric Intensive Care Units
  • Average Daily Census: 80 - 90%
  • Accredited by the Joint Commission and a Magnet Facility
  • Expansion project added 20% more beds in 2012
  • Fully integrated prescriber order entry clinical information system

Resident Salary & Benefits

  • Stipend: $45,500.00
  • 18 Paid Time Off Days (Holiday, Vacation and Sick)
  • Comprehensive Medical, Dental and Vision Insurance
  • Additional time for to attend ASHP Midyear Clinical Meeting and Eastern States Residency Conference
  • $2000 travel stipend for education related travel

Curriculum Information

Core Required Rotations (4 Week Duration): Hospital/Pharmacy Orientation (3 weekday afternoons); Medicine ICU (3 blocks); Surgery ICU (3 blocks); Pediatric ICU (1 block); Heart and Vascular ICU (2 blocks); Emergency Medicine (2 blocks)

  • Elective Rotations - Complete 1 (4 Week Duration): Repeat any Core Rotation, Infectious Disease, Medication Safety/Informatics
  • Longitudinal Learning Experiences (4): Inpatient Pharmacy Operations, Pharmacy Administration, Residency Research Project, Education/Academia

ALTBaystate's PGY-2 Pharmacy Residency is pending accreditation by the American Society of Health-System Pharmacists